Borsa Haberleri
Son finansal haberler · Güncellendi Tem 28, 2026
7 Milyar Dolarlık Mükemmel Zamanlanmış Petrol Bahisleri İçeriden Öğrenenlerin Ticareti Korkularını Ateşledi
$7 Billion In Perfectly Timed Oil Bets Sparks Insider Trading Fears
The panel discussed large-scale trades in energy futures that preceded geopolitical announcements, with some suggesting insider trading or market manipulation. …
Citi Veradermics, Incorporated (MANE) Konusunda Yükselişini Sürdürüyor
Citi Remains Bullish on Veradermics, Incorporated (MANE)
The panel is divided on MANE's potential. While some see promise in its Phase 2/3 Part A data and the …
Ripple (XRP) Bu Yıl 10 Büyük Anlaşma Tamamladı: Her Ortaklığın Puan Durumu
Ripple (XRP) Has Closed 10 Major Deals This Year: Here’s the Scoreboard for Each Partnership
Despite Ripple's infrastructure wins, XRP's price performance remains lackluster due to regulatory uncertainty and limited token utility. The market is …
JPMorgan Erasca'yı (ERAS) Mevcut Seviyelerden Almayı Tavsiye Ediyor
JPMorgan Recommends Buying Erasca (ERAS) Stock at Current Levels
The panel consensus is bearish on Erasca (ERAS), with concerns around 'not fully clean' Phase 1 data, safety caveats, and …
Stifel, Tango Therapeutics (TNGX) Konusunda Yükselişini Sürdürüyor
Stifel Remains Bullish on Tango Therapeutics (TNGX)
The panel's discussion on TNGX revolves around the potential of its PRMT5/RAS(ON) combo in pancreatic cancer, with a cash runway …
Leerink Partners Oruka Therapeutics, Inc. (ORKA) Üzerindeki PT'yi Yükseltti
Leerink Partners Lifts PT on Oruka Therapeutics, Inc. (ORKA)
ORKA-001's Phase 2a results are impressive, but its path to market is uncertain due to manufacturing challenges, competition, and commercial …
AnaptysBio (ANAB) 2026 Yılının Şimdiye Kadarki En İyi Performans Gösteren Sağlık Hisselerinden Biri mi?
Is AnaptysBio (ANAB) One of the Best Performing Healthcare Stocks so Far in 2026?
The panel is divided on ANAB's spinoff of TRAX, with some seeing it as a value-enhancing move that separates stable …
Revolution Medicines (RVMD) FDA’dan Daraxonrasib için “Devam Edilebilir” Yazısını Aldı
Revolution Medicines (RVMD) Receives FDA’s “Safe to Proceed” Letter for Daraxonrasib
The panel is mixed on RVMD's 'safe to proceed' EAP, with concerns about the lack of efficacy data, manufacturing challenges, …
RBC Capital, Acadia Healthcare Company (ACHC) İçin Fiyat Hedefini Yükseltti, Q1 Kazançlarını Geride Bıraktı
RBC Capital Lifts PT on Acadia Healthcare Company (ACHC) Following Q1 Earnings Beat
While ACHC's Q1 earnings beat and upgrades suggest potential for EBITDA improvement and a 'harvest' from underperforming facilities, the consensus …
Twist Bioscience Corporation (TWST) 2026 Mali<bos>letme Sonuçlarını Açıkladı
Twist Bioscience Corporation (TWST) Announces Q2 2026 Financial Results
The panelists agree that Twist Bioscience has shown operational momentum with 13 consecutive quarters of growth and a 19% YoY …
Goldman Sachs Broadcom hisse senedi tahminini yeniden belirliyor
Goldman Sachs resets Broadcom stock forecast
The panel is divided on Broadcom's VMware integration, with bulls focusing on potential margin expansion and AI momentum, while bears …
RBC Capital, CG Oncology (CGON) için hedef fiyatı artırdı, PIVOT-006'yi karmaşık bir katalizör olarak vurgular
RBC Capital Lifts PT on CG Oncology (CGON), Calls PIVOT-006 a Complex Catalyst
CG Oncology's stock performance is heavily reliant on the June PIVOT-006 data, with a high risk of a 'sell the …